Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Lonial

Showing results (41-50 of 440) with videos related to

Pageof 44
Sort By:
Onkologie|April 8, 2006
Proteasome inhibition: novel therapy for multiple myelomaJonathan L Kaufman, Sagar Lonial
Oncology (Williston Park, N.Y.)|November 29, 2013
Non-secretory myeloma: a clinician's guideSagar Lonial, Jonathan L Kaufman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
How to Integrate Elotuzumab and Daratumumab Into Therapy for Multiple MyelomaCraig C Hofmeister, Sagar Lonial
Blood|March 12, 2008
Eliminating the complete response penalty from myeloma response assessmentSagar Lonial, Morie A Gertz
Oncology (Williston Park, N.Y.)|January 17, 2017
Insights Into the Appropriate Use of New Antimyeloma TherapiesJonathan L Kaufman, Sagar Lonial
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Is Maintenance Therapy for Everyone?Ajay K Nooka, Sagar Lonial
Leukemia & Lymphoma|February 18, 2011
Putting the E (evidence) in a new Era for myelomaJonathan L Kaufman, Sagar Lonial
Journal of Oncology Practice|April 14, 2016
Myeloma Is Not a Single DiseaseSagar Lonial, Ajay K Nooka
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple MyelomaAjay K Nooka, Sagar Lonial
Expert Opinion on Biological Therapy|April 19, 2005
Immunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activityJason J Everly, Sagar Lonial
Pageof 44

Showing results (41-50 of 440) with videos related to

Sort By:
Pageof 44
Onkologie|April 8, 2006
Proteasome inhibition: novel therapy for multiple myelomaJonathan L Kaufman, Sagar Lonial
Oncology (Williston Park, N.Y.)|November 29, 2013
Non-secretory myeloma: a clinician's guideSagar Lonial, Jonathan L Kaufman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
How to Integrate Elotuzumab and Daratumumab Into Therapy for Multiple MyelomaCraig C Hofmeister, Sagar Lonial
Blood|March 12, 2008
Eliminating the complete response penalty from myeloma response assessmentSagar Lonial, Morie A Gertz
Oncology (Williston Park, N.Y.)|January 17, 2017
Insights Into the Appropriate Use of New Antimyeloma TherapiesJonathan L Kaufman, Sagar Lonial
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Is Maintenance Therapy for Everyone?Ajay K Nooka, Sagar Lonial
Leukemia & Lymphoma|February 18, 2011
Putting the E (evidence) in a new Era for myelomaJonathan L Kaufman, Sagar Lonial
Journal of Oncology Practice|April 14, 2016
Myeloma Is Not a Single DiseaseSagar Lonial, Ajay K Nooka
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple MyelomaAjay K Nooka, Sagar Lonial
Expert Opinion on Biological Therapy|April 19, 2005
Immunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activityJason J Everly, Sagar Lonial
Pageof 44